papaverine has been researched along with daunorubicin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Rosazza, JP; Smith, RV | 1 |
| Helson, L | 1 |
2 review(s) available for papaverine and daunorubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Microbial models for drug metabolism.
Topics: Acronine; Animals; Aporphines; Bacteria; Biotransformation; Cannabinoids; Chemical Phenomena; Chemistry; Cytochrome P-450 Enzyme System; Danazol; Daunorubicin; Ellipticines; Fungi; Indans; Mammals; Models, Biological; Oxidation-Reduction; Oxygenases; Papaverine; Pharmaceutical Preparations; Prostaglandins; Species Specificity; Spironolactone; Thiazoles; Yeasts | 1979 |
2 other study(ies) available for papaverine and daunorubicin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chemotherapy of neuroblastoma.
Topics: Age Factors; Animals; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; In Vitro Techniques; Infant; Mice; Neuroblastoma; Papaverine; Semustine; Time Factors; Vincristine | 1975 |